FRONT MICROBIOL 润色咨询

Frontiers in Microbiology

出版年份:暂无数据 年文章数:26898 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:13.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2025-03-14 ms5000000169069735 来自北京

    审稿速度:3.0 | 投稿命中率:95.0
    经验分享:12月初投稿,3月见刊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2025-01-08 Marianne94 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:疾病;微生物
    经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2024-12-14 仲夏紫风铃 来自上海

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:感染学;微生物
    经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2024-03-01 handan011022 来自辽宁省

    审稿速度:3.0
    经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2021-08-10 803

    快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2024-04-29 ms3000001612686318 来自广西

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:功能;生理特性;微生物
    经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的...

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2024-01-04 一大口内涵 来自山东省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:抗肿瘤肽;抗菌肽
    经验分享:投了一篇综述,审稿效率挺快的
    2023.10.14:Corresponding Author submitted manuscript
    2023.11.6:Three reviewers completed the review process. Interactive review forum activated.
    2023.11.16:返回审稿意见
    2023.11.21:Review of three reviewers finalized and they agreed to publish.

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2024-02-29 ms3000001769120772 来自浙江省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:微生物
    经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2023-09-19 ms6000001160695992 来自四川省

    投稿一个月了还是Editoral assignment,要撤稿吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2256128, encodeId=253d2256128ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:12月初投稿,3月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Mar 14 20:33:38 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247189, encodeId=c7a2224e189d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疾病;微生物<br>经验分享:3月20投的,5月20几号accepted,2个审稿人都偏正向的评价,后来顺利就接了,就是邀请审稿人挺慢的,不过好像是各种杂志的通病吧,现在审稿挺难的。攒攒人品发发经验哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13865246605, createdName=Marianne94, createdTime=Wed Jan 08 22:16:34 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242349, encodeId=cc992242349da, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:感染学;微生物<br>经验分享:很奇怪的杂志,不得不吐槽,第一次修回三个审稿人一个拒一个小修一个接,给了小修,修完回去后一个半月突然被editor拒了,没有给任何意见。感觉很不礼貌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0241701717, createdName=仲夏紫风铃, createdTime=Sat Dec 14 13:05:19 CST 2024, time=2024-12-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190470, encodeId=67b921904e0e0, content=审稿速度:3.0<br>经验分享:有两次投稿F刊经验,感觉期刊审稿很魔幻,一次给了大修机会,让补充实验,按照审稿人的意见补充了,结果被拒,也不说原因,套话糊弄人,不符合本期刊的标准。另一次3个审稿人,其中两个根本不是相关专业的专家,看不懂我的手稿,最后说我们团队不愿意按照他的意见修改,真是很儿戏很水,浪费了作者的宝贵时间,就连等待拒稿都等了一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erJEqa95HvFXAWuxoFGnC03ziaMuiakB7RkCLZLvLrgbOcSkMvZJgWXG7F6qBjbhRaGZmbnflibesgNA/132, createdBy=ea7b2514624, createdName=handan011022, createdTime=Fri Mar 01 20:11:25 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1006750, encodeId=e2691006e5038, content=快3个月了,1个月前完成一个审稿人的修改意见,到现在没有任何其他审稿人出现,郁闷啊,咋办?是催一下编辑还是继续等待?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=320f1634730, createdName=803, createdTime=Tue Aug 10 21:55:34 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200980, encodeId=834d220098040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:功能;生理特性;微生物<br>经验分享:投了一篇微生物论著,这个期刊处理稿件和审稿很快,有时候周末发邮件通知的,20多天内先是两个审稿人意见回来了,审稿人2直接同意发表,审稿人1给大修,编辑给了14天。修回去审稿人1拒了...,编辑再找审稿人3,这个人应该是纯搞微生物的,不懂生理学,给的意见很不友好。特刊主编隔了一天拒了,这个期刊现在不容易投的。中科院2区top,不过frontiers的名声不太好,不知道该刊是否是出淤泥而不染!!处理稿件和审稿还是很快,这点好评,给的意见看情况了,总体还是有水平质量的..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425f9247287, createdName=ms3000001612686318, createdTime=Mon Apr 29 09:52:41 CST 2024, time=2024-04-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2179188, encodeId=b2a621e91884d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:抗肿瘤肽;抗菌肽<br>经验分享:投了一篇综述,审稿效率挺快的<br>2023.10.14:Corresponding Author submitted manuscript<br>2023.11.6:Three reviewers completed the review process. Interactive review forum activated.<br>2023.11.16:返回审稿意见<br>2023.11.21:Review of three reviewers finalized and they agreed to publish., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Thu Jan 04 10:37:44 CST 2024, time=2024-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190086, encodeId=f97d2190086a6, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:12月1日提交,2月27日接收,历时三个月,5个审稿人审了三轮,一共117条意见,意见很犀利,审稿极其专业,审完后看到审稿人是2位国内的微生物专业的博导,1位美国的微生物专业博导,1位英国的微生物专业博导,论文在编辑团队没怎么耽误,效率比较高,尤其是livechat真的好评,别人说这个期刊水不水我不管,我作为一个也有几篇SCI的博士而言,这篇文章是耗时最长,改的最多,最惊心动魄的一次,而且这个文章差点就被EST等顶刊就要了,后来因为要毕业,被顶刊拒了几次后,考虑到时间问题,就投这儿了,咋说呢,接收后还是蛮有成就感的,因为过程太太太艰难了!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50598305717, createdName=ms3000001769120772, createdTime=Thu Feb 29 13:45:24 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2158544, encodeId=6c7121585447a, content=投稿一个月了还是Editoral assignment,要撤稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfa45529837, createdName=ms6000001160695992, createdTime=Tue Sep 19 18:27:30 CST 2023, time=2023-09-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2094582, encodeId=0b34209458225, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物<br>经验分享:今天刚投,期待好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Tue Oct 18 21:57:54 CST 2022, time=2022-10-18, status=1, ipAttribution=)]
    2022-10-18 ms5000000525566741

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:微生物
    经验分享:今天刚投,期待好消息。

    6

    展开6条回复
共310条页码: 1/31页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分